波士顿科学Vercise Genus DBS系统全国上市会顺利举办

美通社2025-05-23

北京2025年5月23日 /美通社/ -- 今日，波士顿科学Vercise Genus™植入式脑深部神经刺激（DBS）系统（简称"Vercise Genus DBS系统"）全国上市会于第十四届亚澳立体定向与功能神经外科学会（AASSFN）年会上成功举办。Vercise Genus DBS系统的上市将为国内帕金森病患者带来更多元的治疗选择，引领中国帕金森病治疗加速迈入精准新时代。帕金森病是中老年人...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537180306?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-23 17:40","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2537180306","market":"hk","top_or_hot":-1,"title":"波士顿科学Vercise Genus DBS系统全国上市会顺利举办","media":"美通社","content":"<div>\n<p>北京2025年5月23日 /美通社/ -- 今日，波士顿科学Vercise Genus™植入式脑深部神经刺激（DBS）系统（简称\"Vercise Genus DBS系统\"）全国上市会于第十四届亚澳立体定向与功能神经外科学会（AASSFN）年会上成功举办。Vercise Genus DBS系统的上市将为国内帕金森病患者带来更多元的治疗选择，引领中国帕金森病治疗加速迈入精准新时代。帕金森病是中老年人...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-05-23/doc-inexpzxx0677769.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>波士顿科学Vercise Genus DBS系统全国上市会顺利举办</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n波士顿科学Vercise Genus DBS系统全国上市会顺利举办\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-23 17:40 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2025-05-23/doc-inexpzxx0677769.shtml><strong>美通社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京2025年5月23日 /美通社/ -- 今日，波士顿科学Vercise Genus™植入式脑深部神经刺激（DBS）系统（简称\"Vercise Genus DBS系统\"）全国上市会于第十四届亚澳立体定向与功能神经外科学会（AASSFN）年会上成功举办。Vercise Genus DBS系统的上市将为国内帕金森病患者带来更多元的治疗选择，引领中国帕金森病治疗加速迈入精准新时代。帕金森病是中老年人...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-05-23/doc-inexpzxx0677769.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RJAW.SI","symbol_name":"DBS MB ePW240902","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-05-23/doc-inexpzxx0677769.shtml","article_id":"2537180306","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537180306","pubTimestamp":1747993200,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"Vercise Genus DBS系统的上市将为国内帕金森病患者带来更多元的治疗选择，引领中国帕金森病治疗加速迈入精准新时代。波士顿科学的Vercise Genus DBS系统可协助医生优化靶点位置设定和刺激参数选择，满足患者个性化需求，助力帕金森病患者收获更多治疗收益。2024年10月，Vercise Genus DBS系统已获得国家药监局批准，并于今年4月在国内完成首批临床应用。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RJAW.SI":"DBS MB ePW240902","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","SG9999001846.SGD":"Schroder Asian Equity Yield A Dis SGD","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0823397103.USD":"BNP PARIBAS SUSTAINABLE ASIA EX-JAPAN EQUITY \"C\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0326948709.USD":"SCHRODER ISF ASIAN TOTAL RETURN \"A\" (USD) ACC","IE0031814969.USD":"FSSA ASEAN ALL CAP FUND \"I\" (USD) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU0048573645.USD":"富达东盟基金","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0235996351.USD":"UBS (LUX) KEY SELECTION SICAV - ASIAN EQUITY (USD) \"P\" (USD) ACC","BK4588":"碎股","DBS":"Invesco DB Silver Fund","LU0672654166.SGD":"FTIF - Templeton Asian Growth A (acc) SGD-H1","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0577902611.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"A\" (USD) ACC","SG9999002406.SGD":"利安新加坡信托基金","BSX":"波士顿科学","SGXZ43160589.SGD":"UNITED SG DYNAMIC INCOME FUND \"A\" (SGD) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","LU0737861269.HKD":"FIDELITY ASEAN \"A \" (HKD) ACC","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0096374516.USD":"CT (LUX) I ASIA EQUITY INCOME \"DU\" (USD) ACC","LU0882747503.HKD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (HKD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","D05.SI":"星展集团控股","LU0048597586.USD":"富达亚洲焦点A","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU0261947096.USD":"FIDELITY FUNDS  SUSTAINABLE ASIA EQUITY \"A\" (USD) ACC","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD","LU1130305938.SGD":"Schroder ISF Asian Dividend Maximiser A Dis SGD-H","LU0238689110.USD":"贝莱德环球动力股票基金","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU2257852520.SGD":"JPMorgan Funds - Asia Growth A (acc) SGD","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU0831093199.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM3\" (SGDHDG) INC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","SG9999014484.SGD":"Nikko AM ASEAN Equity Fund A SGD","LU0882574055.USD":"富达全球健康医疗A ACC"},"translate_title":"Boston Scientific's Vercise Genus DBS system national launch meeting was successfully held","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DBS":1,"RJAW.SI":1,"D05.SI":1,"BSX":1},"content_text":"北京2025年5月23日 /美通社/ -- 今日，波士顿科学Vercise Genus™植入式脑深部神经刺激（DBS）系统（简称\"Vercise Genus DBS系统\"）全国上市会于第十四届亚澳立体定向与功能神经外科学会（AASSFN）年会上成功举办。Vercise Genus DBS系统的上市将为国内帕金森病患者带来更多元的治疗选择，引领中国帕金森病治疗加速迈入精准新时代。帕金森病是中老年人常见的神经系统退行性疾病。中国流行病学调查数据显示，中国有着数量最大的帕金森病患者群体，2021年帕金森病患者人数已超过500万，发病率也高于全球平均[1]。帕金森病严重影响患者生活质量，且目前无法治愈。虽然药物治疗可控制部分症状，但药效会随着病情发展逐渐变差，还可能会产生副作用。DBS疗法则因其微创、可逆、可调节等优点，成为安全有效的治疗手段。该疗法可通过在脑部植入电极刺激目标神经核团，调控相关神经环路，改善运动症状并减少药物使用。波士顿科学的Vercise Genus DBS系统可协助医生优化靶点位置设定和刺激参数选择，满足患者个性化需求，助力帕金森病患者收获更多治疗收益。2024年10月，Vercise Genus DBS系统已获得国家药监局批准，并于今年4月在国内完成首批临床应用。本新闻稿包含美国 1933 年《证券法》第 27A 节和 1934 年《证券交易法》第 21E 节意义范畴内的前瞻性陈述。前瞻性陈述可以用诸如\"预料\"、\"预期\"、\"预测\"、\"相信\"、\"计划\"、\"估计\"、\"打算\"及类似的词进行标识。这些前瞻性陈述是基于我们当时可获得的信息而得出的看法、假设和估计，而非用于对未来的事件或业绩进行保证。这些前瞻性陈述包括我们对此次交易的财务和商业影响、我们的商业计划和产品性能和影响等的陈述。如果我们的基本假设被证明是错误的，或者如果某些风险或不确定性变成现实，那么实际结果可能会与我们的前瞻性陈述中所明示或所暗示的预期和预测结果存在重大差异。这些因素在某些情况下已经影响并且在未来（结合其他因素）还可能会影响我们实施业务战略的能力，并可能导致实际结果与本新闻稿中的预期结果大相径庭。因此，我们告诫读者不要过度依赖我们的任何前瞻性陈述。可能导致这种差异的因素包括：未来经济状况、竞争状况、薪酬和监管条件；制造、分销和供应链中断及成本增加；新产品的引入；产品性能；人口发展趋势；知识产权；诉讼；金融市场情况；以及我们和竞争对手未来的商业决策。所有这些因素均难以或无法准确预测，其中许多因素我们无法控制。欲了解可能会影响我们未来业务的重要风险和不确定性因素的详细列表和描述，请参阅我们呈交美国证券交易委员会的最新 10-K 年度报告中的第一部分 1A 项\"风险因素\"。在已提交或之后将提交的 10-Q 季度报告的第二部分第 1A 项\"风险因素\"中，我们可能会更新这部分内容。我们没有意图也没有义务公开更新或修改任何前瞻性陈述以反映一些变化，这些变化可能是我们的预期改变，或是这些预期所依据的事件、条件或环境发生了改变，亦或是那些可能导致实际结果和前瞻性陈述中的结果出现差异的变化。本警示性声明适用于本文档中所有前瞻性陈述。波士顿科学公司承诺为生命创新。我们致力于创新医疗解决方案，改善全球患者生活。超过45年来，波士顿科学始终引领全球医疗技术行业的发展，通过提供各种广泛的高性能医疗解决方案，满足广大患者亟待解决的治疗需求，降低医疗保健成本。波士顿科学的医疗器械及相关疗法可以帮助医生诊断和治疗复杂的心血管、呼吸、消化、肿瘤、神经和泌尿系统疾病。波士顿科学于1997年在上海设立中国区总部，开启在华业务，目前在北京、广州、成都、香港、台北设有分支机构。公司核心业务范围涵盖心脏介入、心脏节律管理、房颤解决方案、外周介入、肿瘤介入、内窥镜介入、泌尿、神经调控及呼吸介入等。秉承创新引领者的传统，通过提供疾病预防、诊断及治疗的医疗产品及服务，波士顿科学致力于成为一家贴近医患需求、具有创新活力的医疗科技公司。更多详细信息，请访问公司网站：www.bostonscientific.cn[1] 中国帕金森病报告2025[J]. 神经病学与神经康复学杂志. 2025, 21(2): 63-98 https://doi.org/10.12022/jnnr.2025-0003[2] Compared with standard clinical based programming, p=0.039[3] Vitek et al., Subthalamic Nucleus Deep Brain Stimulation with a Multiple Independent Constant Current-Controlled Device in Parkinson's Disease (INTREPID): Multicentre, Double-Blind, Randomised, Sham-Controlled Study, Lancet Neurology, 2020\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537180306","isCrawlerRequest":true}